Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Gastrointestinal hormones with insulinotropic effects, like cholecystokinin (CCK) and gastric inhibitory polypeptide (GIP) might tentatively be used in the treatment of non-insulin-dependent diabetes mellitus. We therefore examined the effects of intravenous injection of pharmacological dose levels of CCK-8 (100 and 300 pmol/kg), CCK-33 (100 pmol/kg), GIP (100 pmol/kg), and CCK-8 plus GIP (100 pmol/kg of each) on plasma levels of glucose, insulin, somatostatin, glucagon, and pancreatic polypeptide (PP) in healthy human volunteers. The peptides were given under basal conditions or in combination with a mixed meal. CCK-8, CCK-33, and GIP were all found to increase the basal plasma levels of insulin, somatostatin, and PP; the increases were observed already in samples taken at 2 min after the injection. In contrast, the plasma glucagon levels were unaffected by the peptides. CCK-8, CCK-33, and GIP (100 pmol/kg) all potentiated the meal-induced plasma responses of insulin and PP, whereas plasma levels of glucagon after the meal were not affected. Plasma somatostatin levels after the meal were increased by GIP but not affected by CCK-8 or CCK-33. CCK-8 and GIP together (100 pmol/kg for both) increased plasma levels of insulin, PP and somatostatin as much as each of the peptides given alone, both under basal conditions and after the meal intake. Plasma levels of glucagon were not affected by CCK-8 and GIP together. We conclude that in man, both CCK-8, CCK-33, and GIP moderately stimulate basal and meal related insulin release without any synergistic effects and that the peptides do not inhibit the secretion of glucagon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CCK, which is synthesized and released from duodenal I-cells, potentiates basal, glucose-236, 237 and amino acid-induced insulin secretion,238 and augments glucagon secretion.237, 239”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [236]
Citations
Cites
Labelled proteins in tracer studies
Taylor, D. M. (1967) · The International Journal of Applied Radiation and Isotopes · doi:10.1016/0020-708x(67)90023-3 · Cited by 261
Ipp, E., Dobbs, R. E., Arimura, A., Vale, W., Harris, V, & Unger, R. H. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108829 · Cited by 163
PEDERSON, R. A., & BROWN, J. C. (1978) · Endocrinology · doi:10.1210/endo-103-2-610 · Cited by 156
Krarup, T., Madsbad, S., Moody, A. J., Regeur, L., Faber, O. K., Holst, J. J., & Sestoft, L. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-6-1306 · Cited by 151
Krarup, T., Saurbrey, N., Moody, A. J., Kühl, C., & Madsbad, S. (1987) · Metabolism · doi:10.1016/0026-0495(87)90153-3 · Cited by 146
Himeno, S., Tarui, S., Kanayama, S., Kuroshima, T., Shinomura, Y., Hayashi, C., Tateishi, K., Imagawa, K., Hashimura, E., & Hamaoka, T. (1983) · PubMed · Cited by 146
Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas
Adrian, T. E., Bloom, S. R., Hermansen, K., & Iversen, J. (1978) · Diabetologia · doi:10.1007/bf01228136 · Cited by 130
NAUCK, M., SCHMIDT, W. E., EBERT, R., STRIETZEL, J., CANTOR, P., HOFFMANN, G., & CREUTZFELDT, W. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-654 · Cited by 108
Release of pancreatic polypeptide in humans by infusion of cholecystokinin
Lonovics, J., GUZMAN, S., Devitt, P. G., Hejtmancik, K. E., Suddith, R. L., Rayford, P. L., & Thompson, J. C. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90435-7 · Cited by 108
RUSHAKOFF, R. J., GOLDFINE, I. D., CARTER, J. D., & LIDDLE, R. A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-395 · Cited by 96
Research works printed but not linked: 1
- Hildebrand, 1990, Cholecystokinin (CCK) is not an incretin in humans, Digestion, 46, 143
Cited by
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Cholecystokinin and Gastrin Receptors
Dufresne, M., Seva, C., & Fourmy, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00014.2005 · Cited by 476
“CCK to stimulate insulin secretion is controversial (5, 141, 151, 249, 284, 424).”
Background2-Oleoyl Glycerol Is a GPR119 Agonist and Signals GLP-1 Release in Humans
Hansen, K. B., Rosenkilde, M. M., Knop, F. K., Wellner, N., Diep, T. A., Rehfeld, J. F., Andersen, U. B., Holst, J. J., & Hansen, H. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0647 · Cited by 297
Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome
Berntson, G. G., Zipf, W. B., O’Dorisio, T. M., Hoffman, J. A., & Chance, R. E. (1993) · Peptides · doi:10.1016/0196-9781(93)90138-7 · Cited by 137
Glucose-dependent insulinotropic polypeptide (GIP)
Müller, T. D., Adriaenssens, A. E., Ahrén, B., Blüher, M., Birkenfeld, A. L., Campbell, J. E., Coghlan, M. P., D’Alessio, D. D., Deacon, C. F., DelPrato, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102118 · Cited by 112
Self-citation
Metadata
- Authors
- Ahrén, B., Pettersson, M., Uvnäs-Moberg, K., Gutniak, M., & Efendic, S.
- Affiliations
- Lund University (SE)
- Karolinska University Hospital (SE)
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 1991-09
- Volume
- 13
- Issue
- 3
- Pages
- 153-161
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2167719373
- Cited by
- 50
- References
- 34
- Citations by year
- 2026: 1 · 2025: 2 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2016: 3 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 3
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Diabetes Research and Clinical Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- cholecystokinin-8, glucose-dependent insulinotropic polypeptide, insulin secretion, pancreatic hormone secretion, somatostatin, glucagon, pancreatic polypeptide, type 2 diabetes, gastrointestinal hormones, synergistic effect
- MeSH terms
- Insulin Secretion, Adult, Blood Glucose, Cholecystokinin, Eating, Female, Gastric Inhibitory Polypeptide, Glucagon, Humans, Insulin, Kinetics, Male, Pancreatic Hormones, Pancreatic Polypeptide, Reference Values, Sincalide, Somatostatin, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man. https://app.cochat.ai/papers/10.1016/0168-8227(91)90059-m
- The paper
- Ahrén, B., Pettersson, M., Uvnäs-Moberg, K., Gutniak, M., & Efendic, S. (1991). Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man. Diabetes Research and Clinical Practice. https://doi.org/10.1016/0168-8227(91)90059-m
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.